Universal Health International Group Holding Past Earnings Performance
Past criteria checks 2/6
Universal Health International Group Holding has been growing earnings at an average annual rate of 29.9%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been declining at an average rate of 12.8% per year. Universal Health International Group Holding's return on equity is 0.2%, and it has net margins of 0.04%.
Key information
29.9%
Earnings growth rate
35.1%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | -12.8% |
| Return on equity | 0.2% |
| Net Margin | 0.04% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Universal Health International Group Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,089 | 0 | 206 | 0 |
| 31 Mar 24 | 1,090 | -41 | 231 | 0 |
| 31 Dec 23 | 1,091 | -82 | 257 | 0 |
| 30 Sep 23 | 1,194 | -94 | 280 | 0 |
| 30 Jun 23 | 1,297 | -105 | 303 | 0 |
| 31 Mar 23 | 1,375 | -106 | 317 | 0 |
| 31 Dec 22 | 1,454 | -106 | 331 | 0 |
| 30 Sep 22 | 1,364 | -147 | 356 | 0 |
| 30 Jun 22 | 1,274 | -188 | 380 | 0 |
| 31 Mar 22 | 1,244 | -366 | 440 | 0 |
| 31 Dec 21 | 1,214 | -544 | 500 | 0 |
| 30 Sep 21 | 1,200 | -610 | 550 | 0 |
| 30 Jun 21 | 1,185 | -675 | 600 | 0 |
| 31 Mar 21 | 1,108 | -627 | 644 | 0 |
| 31 Dec 20 | 1,031 | -578 | 687 | 0 |
| 30 Sep 20 | 1,270 | -535 | 690 | 0 |
| 30 Jun 20 | 1,510 | -491 | 693 | 0 |
| 31 Mar 20 | 1,816 | -408 | 662 | 0 |
| 31 Dec 19 | 2,122 | -324 | 631 | 0 |
| 30 Sep 19 | 2,273 | -295 | 631 | 0 |
| 30 Jun 19 | 2,424 | -266 | 631 | 0 |
| 31 Dec 18 | 2,667 | -253 | 668 | 0 |
| 30 Sep 18 | 2,656 | -432 | 701 | 0 |
| 30 Jun 18 | 2,646 | -611 | 735 | 0 |
| 31 Dec 17 | 2,680 | -553 | 747 | 0 |
| 30 Sep 17 | 2,744 | -404 | 760 | 0 |
| 30 Jun 17 | 2,807 | -256 | 772 | 0 |
| 31 Mar 17 | 3,093 | -172 | 796 | 0 |
| 31 Dec 16 | 3,379 | -88 | 819 | 0 |
| 30 Sep 16 | 3,759 | -108 | 957 | 0 |
| 30 Jun 16 | 4,139 | -128 | 1,095 | 0 |
| 31 Mar 16 | 4,472 | -48 | 1,095 | 0 |
| 31 Dec 15 | 4,806 | 31 | 1,095 | 0 |
| 30 Sep 15 | 4,844 | 262 | 905 | 0 |
| 30 Jun 15 | 4,883 | 494 | 716 | 0 |
| 31 Mar 15 | 4,619 | 483 | 654 | 0 |
| 31 Dec 14 | 4,356 | 473 | 592 | 0 |
| 30 Sep 14 | 4,133 | 450 | 560 | 0 |
| 30 Jun 14 | 3,910 | 428 | 529 | 0 |
| 31 Mar 14 | 3,617 | 392 | 472 | 0 |
| 31 Dec 13 | 3,323 | 355 | 416 | 0 |
Quality Earnings: 2211 has a high level of non-cash earnings.
Growing Profit Margin: 2211 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2211 has become profitable over the past 5 years, growing earnings by 29.9% per year.
Accelerating Growth: 2211 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2211 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).
Return on Equity
High ROE: 2211's Return on Equity (0.2%) is considered low.